Neoleukin Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Neoleukin Therapeutics's estimated annual revenue is currently $18.1M per year.
- Neoleukin Therapeutics's estimated revenue per employee is $1,066,765
- Neoleukin Therapeutics's total funding is $157.6M.
Employee Data
- Neoleukin Therapeutics has 17 Employees.
- Neoleukin Therapeutics grew their employee count by -66% last year.
Neoleukin Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Corporate Development | Reveal Email/Phone |
2 | Senior Director Translational Science | Reveal Email/Phone |
3 | Interim Chief Financial Officer | Reveal Email/Phone |
4 | Senior Director, Legal | Reveal Email/Phone |
5 | Sr. Director, Program Management | Reveal Email/Phone |
6 | Senior Director, Clinical Science | Reveal Email/Phone |
7 | Chief Medical Officer | Reveal Email/Phone |
8 | Chief Financial Officer | Reveal Email/Phone |
9 | Director, People Team | Reveal Email/Phone |
10 | Associate Project Manager | Reveal Email/Phone |
Neoleukin Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $5.7M | 37 | 42% | N/A | N/A |
#5 | $1.4M | 18 | -10% | N/A | N/A |
#6 | $3.7M | 48 | -21% | $16M | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $0.8M | 5 | -81% | N/A | N/A |
#9 | $2.5M | 16 | -27% | N/A | N/A |
#10 | $0.8M | 5 | -17% | N/A | N/A |
What Is Neoleukin Therapeutics?
Neoleukin Therapeutics emerged from the University of Washington Institute for Protein Design in January of 2019. We are creating next generation immunotherapies using breakthrough de novo protein design technology. We use natural protein complexes as inspiration to develop custom designed proteins with superior pharmaceutical properties.
keywords:N/A
$157.6M
Total Funding
17
Number of Employees
$18.1M
Revenue (est)
-66%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Neoleukin Therapeutics News
Neoleukin Therapeutics Announces Preclinical Data for NL-201 at American Association for Cancer Research (AACR) Annual Meeting.
Neoleukin Therapeutics, Inc. - NL-201 demonstrates antitumor activity in preclinical B-cell lymphoma models -. - NL-201 synergizes with...
Neoleukin is a biopharmaceutical company creating next generation immunotherapies for cancer, inflammation and autoimmunity using de novo...
Neoleukin Therapeutics launched in January with the goal of commercializing a cancer-fighting protein that was designed from scratch at the University of Washington. (UW Photo) Vancouver, B.C.-based Aquinox Pharmaceuticals is set to buy Neoleukin Therapeutics, a Seattle startup that launched ou ...
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.5M | 17 | -11% | N/A |
#2 | $1.5M | 17 | N/A | N/A |
#3 | $1.4M | 17 | N/A | N/A |
#4 | $3.3M | 17 | N/A | N/A |
#5 | $0.5M | 17 | -6% | $29M |